| Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers MJ Potthoff, H Wu, MA Arnold, JM Shelton, J Backs, J McAnally, ... The Journal of clinical investigation 117 (9), 2459-2467, 2007 | 497 | 2007 |
| MEF2C transcription factor controls chondrocyte hypertrophy and bone development MA Arnold, Y Kim, MP Czubryt, D Phan, J McAnally, X Qi, JM Shelton, ... Developmental cell 12 (3), 377-389, 2007 | 496 | 2007 |
| Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c MJ Potthoff, MA Arnold, J McAnally, JA Richardson, R Bassel-Duby, ... Molecular and cellular biology 27 (23), 8143-8151, 2007 | 256 | 2007 |
| Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015 LM Turcotte, Q Liu, Y Yasui, MA Arnold, S Hammond, RM Howell, ... JAMA 317 (8), 814-824, 2017 | 253 | 2017 |
| Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation M Haberland, MA Arnold, J McAnally, D Phan, Y Kim, EN Olson Molecular and cellular biology 27 (2), 518-525, 2007 | 193 | 2007 |
| PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells CA Davis, M Haberland, MA Arnold, LB Sutherland, OG McDonald, ... Molecular and cellular biology 26 (7), 2626-2636, 2006 | 168 | 2006 |
| Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2 O Nakagawa, M Arnold, M Nakagawa, H Hamada, JM Shelton, H Kusano, ... Genes & development 19 (17), 2066-2077, 2005 | 142 | 2005 |
| A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway E Bush, J Fielitz, L Melvin, M Martinez-Arnold, TA McKinsey, R Plichta, ... Proceedings of the National Academy of Sciences 101 (9), 2870-2875, 2004 | 109 | 2004 |
| Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group ER Rudzinski, JR Anderson, YY Chi, JM Gastier‐Foster, C Astbury, ... Pediatric blood & cancer 64 (12), e26645, 2017 | 97 | 2017 |
| Chemotherapy and risk of subsequent malignant neoplasms in the childhood cancer survivor study cohort LM Turcotte, Q Liu, Y Yasui, TO Henderson, TM Gibson, W Leisenring, ... Journal of Clinical Oncology 37 (34), 3310, 2019 | 90 | 2019 |
| Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C M Schwieger, A Schüler, M Forster, A Engelmann, MA Arnold, R Delwel, ... Blood, The Journal of the American Society of Hematology 114 (12), 2476-2488, 2009 | 89 | 2009 |
| The MADS transcription factor Mef2c is a pivotal modulator of myeloid cell fate A Schüler, M Schwieger, A Engelmann, K Weber, S Horn, U Müller, ... Blood, The Journal of the American Society of Hematology 111 (9), 4532-4541, 2008 | 72 | 2008 |
| Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low‐Risk Clinical Features: A Report From the Children's Oncology Group MA Arnold, JR Anderson, JM Gastier‐Foster, FG Barr, SX Skapek, ... Pediatric blood & cancer 63 (4), 634-639, 2016 | 68 | 2016 |
| IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis AC Gross, H Cam, DA Phelps, AJ Saraf, HK Bid, M Cam, CA London, ... JCI insight 3 (16), 2018 | 66 | 2018 |
| The cutting edge of serrated polyps: a practical guide to approaching and managing serrated colon polyps BN Limketkai, D Lam-Himlin, MA Arnold, CA Arnold Gastrointestinal endoscopy 77 (3), 360-375, 2013 | 64 | 2013 |
| Neutropenic enterocolitis: new insights into a deadly entity T Sachak, MA Arnold, BV Naini, RP Graham, SS Shah, M Cruise, JY Park, ... The American Journal of Surgical Pathology 39 (12), 1635-1642, 2015 | 63 | 2015 |
| Myospryn is a direct transcriptional target for MEF2A that encodes a striated muscle, α-actinin-interacting, costamere-localized protein JT Durham, OM Brand, M Arnold, JG Reynolds, L Muthukumar, H Weiler, ... Journal of Biological Chemistry 281 (10), 6841-6849, 2006 | 63 | 2006 |
| Molecular diagnostics in the management of rhabdomyosarcoma MA Arnold, FG Barr Expert review of molecular diagnostics 17 (2), 189-194, 2017 | 59 | 2017 |
| A unique pattern of INI1 immunohistochemistry distinguishes synovial sarcoma from its histologic mimics MA Arnold, CA Arnold, G Li, U Chae, R El-Etriby, CCR Lee, M Tsokos Human pathology 44 (5), 881-887, 2013 | 57 | 2013 |
| Association of Breast Cancer Risk After Childhood Cancer With Radiation Dose to the Breast and Anthracycline Use: A Report From the Childhood Cancer Survivor Study LH Veiga, RE Curtis, LM Morton, DR Withrow, RM Howell, SA Smith, ... JAMA pediatrics 173 (12), 1171-1179, 2019 | 56 | 2019 |
John M. SheltonSenior Research Scientist, UT SouthwesternVerified email at utsouthwestern.edu
